![BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers | Science Translational Medicine BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers | Science Translational Medicine](https://www.science.org/cms/asset/aff01e29-3536-466a-9bbc-a839e7e344f4/aax2625-f1.gif)
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers | Science Translational Medicine
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
![Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression - QIMA Life Sciences Oncostatin M is overexpressed in skin squamous-cell carcinoma and promotes tumor progression - QIMA Life Sciences](https://qima-lifesciences.com/wp-content/uploads/2019/09/mw_Oncostatin-M-2019.png)